Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

639
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
639
GPCR Desensitization01:12

GPCR Desensitization

7.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

717
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
717
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-target mu opioid-dopamine D<sub>3</sub> receptor (MOR-D<sub>3</sub>R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesics.

European journal of medicinal chemistry·2026
Same author

Local GPCR density tips the balance of μ-opioid receptor trafficking.

bioRxiv : the preprint server for biology·2026
Same author

Membrane Permeability Drives the Extreme Potency of Fentanyl.

JACS Au·2026
Same author

Differential inhibition of the diverse behavioural effects of mu-opioid receptor agonists by progressive receptor depletion.

Neuropharmacology·2026
Same author

Design, Synthesis, and Characterization of Novel, Subtype-Selective Fluorescent Antagonists Targeting the Nociceptin/Orphanin FQ Opioid Peptide Receptor.

Journal of medicinal chemistry·2025
Same author

Membrane Permeability Drives the Extreme Potency of Fentanyl but not Isotonitazene.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Dec 2, 2025

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.1K

GRKs as Key Modulators of Opioid Receptor Function.

Laura Lemel1,2, J Robert Lane1,2, Meritxell Canals1,2

  • 1Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK.

Cells
|November 5, 2020
PubMed
Summary
This summary is machine-generated.

G protein-coupled receptor kinases (GRKs) mediate mu-opioid receptor (MOR) phosphorylation, influencing pain relief, tolerance, and addiction. This review details GRK roles in MOR signaling and opioid drug mechanisms.

Keywords:
GPCRGRKkinasesopioid

More Related Videos

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.8K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.6K

Related Experiment Videos

Last Updated: Dec 2, 2025

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.1K
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

16.8K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.6K

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Agonist-induced phosphorylation of the mu-opioid receptor (MOR) is crucial for understanding opioid analgesics, tolerance, and addiction.
  • G protein-coupled receptor kinases (GRKs) are key mediators of opioid receptor C-tail phosphorylation.

Purpose of the Study:

  • To review the current understanding of GRK involvement in opioid receptor actions.
  • To focus on the role of GRKs in the signaling of the mu-opioid receptor (MOR).

Main Methods:

  • Phosphosite-specific antibodies for detecting phosphorylated residues.
  • Mass spectrometry for identifying phosphorylated sites.
  • Mutant knock-in mice to study GRK regulation in vivo.

Main Results:

  • GRKs mediate phosphorylation of specific residues on the C-tail of opioid receptors.
  • These phosphorylation events are critical for MOR-mediated physiological effects.
  • GRK regulation impacts opioid-induced tolerance and addiction mechanisms.

Conclusions:

  • GRKs are central to understanding MOR signaling pathways.
  • Targeting GRK-mediated MOR phosphorylation may lead to novel analgesic strategies.
  • Further research into GRK roles is vital for developing safer opioid-based therapeutics.